Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel Plus Cyclophosphamide vs Anthracycline-Based Chemotherapy in HER2-Negative Breast Cancer
NCT01547741Phase 3Completed
- Sponsor
- NSABP Foundation
- Start
- Apr 2012
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of docetaxel, cyclophosphamide in breast cancer, sponsored by NSABP Foundation. Started Apr 2012; status: completed.
02
Drugs
docetaxelcyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01547741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01547741.